125 related articles for article (PubMed ID: 21445776)
1. Tumor pO₂ as a surrogate marker to identify therapeutic window during metronomic chemotherapy of 9L gliomas.
Mupparaju S; Hou H; Lariviere JP; Swartz HM; Khan N
Adv Exp Med Biol; 2011; 701():107-13. PubMed ID: 21445776
[TBL] [Abstract][Full Text] [Related]
2. Repeated tumor oximetry to identify therapeutic window during metronomic cyclophosphamide treatment of 9L gliomas.
Mupparaju S; Hou H; Lariviere JP; Swartz H; Jounaidi Y; Khan N
Oncol Rep; 2011 Jul; 26(1):281-6. PubMed ID: 21503586
[TBL] [Abstract][Full Text] [Related]
3. Tissue pO2 of orthotopic 9L and C6 gliomas and tumor-specific response to radiotherapy and hyperoxygenation.
Khan N; Li H; Hou H; Lariviere JP; Gladstone DJ; Demidenko E; Swartz HM
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):878-85. PubMed ID: 19136221
[TBL] [Abstract][Full Text] [Related]
4. Repeated assessment of orthotopic glioma pO(2) by multi-site EPR oximetry: a technique with the potential to guide therapeutic optimization by repeated measurements of oxygen.
Khan N; Mupparaju S; Hou H; Williams BB; Swartz H
J Neurosci Methods; 2012 Feb; 204(1):111-117. PubMed ID: 22079559
[TBL] [Abstract][Full Text] [Related]
5. Recurrent low-dose chemotherapy to inhibit and oxygenate head and neck tumors.
Khan N; Hou H; Hodge S; Kuppusamy M; Chen EY; Eastman A; Kuppusamy P; Swartz HM
Adv Exp Med Biol; 2014; 812():105-111. PubMed ID: 24729221
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle and glioma oxygenation by carbogen inhalation in rats: a longitudinal study by EPR oximetry using single-probe implantable oxygen sensors.
Hou H; Khan N; Lariviere J; Hodge S; Chen EY; Jarvis LA; Eastman A; Williams BB; Kuppusamy P; Swartz HM
Adv Exp Med Biol; 2014; 812():97-103. PubMed ID: 24729220
[TBL] [Abstract][Full Text] [Related]
7. Effect of hyperoxygenation on tissue pO2 and its effect on radiotherapeutic efficacy of orthotopic F98 gliomas.
Khan N; Mupparaju S; Hekmatyar SK; Hou H; Lariviere JP; Demidenko E; Gladstone DJ; Kauppinen RA; Swartz HM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1193-200. PubMed ID: 20813466
[TBL] [Abstract][Full Text] [Related]
8. In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI.
Kadayakkara DK; Janjic JM; Pusateri LK; Young WB; Ahrens ET
Magn Reson Med; 2010 Nov; 64(5):1252-9. PubMed ID: 20860007
[TBL] [Abstract][Full Text] [Related]
9. Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma model.
Wu J; Waxman DJ
Cancer Lett; 2014 Oct; 353(2):272-80. PubMed ID: 25069038
[TBL] [Abstract][Full Text] [Related]
10. Dynamic changes in oxygenation of intracranial tumor and contralateral brain during tumor growth and carbogen breathing: a multisite EPR oximetry with implantable resonators.
Hou H; Dong R; Li H; Williams B; Lariviere JP; Hekmatyar SK; Kauppinen RA; Khan N; Swartz H
J Magn Reson; 2012 Jan; 214(1):22-8. PubMed ID: 22033225
[TBL] [Abstract][Full Text] [Related]
11. Increased tumor oxygenation and drug uptake during anti-angiogenic weekly low dose cyclophosphamide enhances the anti-tumor effect of weekly tirapazamine.
Doloff JC; Khan N; Ma J; Demidenko E; Swartz HM; Jounaidi Y
Curr Cancer Drug Targets; 2009 Sep; 9(6):777-88. PubMed ID: 19754361
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the changes in 9L and C6 glioma pO2 by EPR oximetry as a prognostic indicator of differential response to radiotherapy.
Hou H; Mupparaju SP; Lariviere JP; Hodge S; Gui J; Swartz HM; Khan N
Radiat Res; 2013 Mar; 179(3):343-51. PubMed ID: 23391148
[TBL] [Abstract][Full Text] [Related]
13. Repeated tumor pO(2) measurements by multi-site EPR oximetry as a prognostic marker for enhanced therapeutic efficacy of fractionated radiotherapy.
Hou H; Lariviere JP; Demidenko E; Gladstone D; Swartz H; Khan N
Radiother Oncol; 2009 Apr; 91(1):126-31. PubMed ID: 19013657
[TBL] [Abstract][Full Text] [Related]
14. Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and bold MRI study.
Hou H; Khan N; O'Hara JA; Grinberg OY; Dunn JF; Abajian MA; Wilmot CM; Makki M; Demidenko E; Lu S; Steffen RP; Swartz HM
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):834-43. PubMed ID: 15183487
[TBL] [Abstract][Full Text] [Related]
15. Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study.
Dunn JF; O'Hara JA; Zaim-Wadghiri Y; Lei H; Meyerand ME; Grinberg OY; Hou H; Hoopes PJ; Demidenko E; Swartz HM
J Magn Reson Imaging; 2002 Nov; 16(5):511-21. PubMed ID: 12412027
[TBL] [Abstract][Full Text] [Related]
16. Modulation of tumor hypoxia by topical formulations with vasodilators for enhancing therapy.
Abramovic Z; Hou H; Julijana K; Sentjurc M; Lariviere JP; Swartz HM; Khan N
Adv Exp Med Biol; 2011; 701():75-82. PubMed ID: 21445772
[TBL] [Abstract][Full Text] [Related]
17. Effect of a topical vasodilator on tumor hypoxia and tumor oxygen guided radiotherapy using EPR oximetry.
Hou H; Abramovic Z; Lariviere JP; Sentjurc M; Swartz H; Khan N
Radiat Res; 2010 May; 173(5):651-8. PubMed ID: 20426665
[TBL] [Abstract][Full Text] [Related]
18. Increased oxygenation of intracranial tumors by efaproxyn (efaproxiral), an allosteric hemoglobin modifier: In vivo EPR oximetry study.
Hou H; Khan N; O'Hara JA; Grinberg OY; Dunn JF; Abajian MA; Wilmot CM; Demidenko E; Lu S; Steffen RP; Swartz HM
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1503-9. PubMed ID: 15817356
[TBL] [Abstract][Full Text] [Related]
19. Synergistic combination of hyperoxygenation and radiotherapy by repeated assessments of tumor pO2 with EPR oximetry.
Hou H; Dong R; Lariviere JP; Mupparaju SP; Swartz HM; Khan N
J Radiat Res; 2011; 52(5):568-74. PubMed ID: 21799293
[TBL] [Abstract][Full Text] [Related]
20. Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide.
Ferrer-Font L; Arias-Ramos N; Lope-Piedrafita S; Julià-Sapé M; Pumarola M; Arús C; Candiota AP
NMR Biomed; 2017 Sep; 30(9):. PubMed ID: 28570014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
